PTC THERAPEUTICS, INC. Quarterly Marketable Securities, Current in USD from Q2 2013 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Ptc Therapeutics, Inc. quarterly Marketable Securities, Current history and growth rate from Q2 2013 to Q2 2024.
  • Ptc Therapeutics, Inc. Marketable Securities, Current for the quarter ending June 30, 2024 was $439M, a 238% increase year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $439M +$309M +238% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $336M +$218M +183% Mar 31, 2024 10-Q 2024-04-25
Q4 2023 $283M +$152M +116% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 $130M -$54.4M -29.5% Sep 30, 2023 10-Q 2023-10-26
Q2 2023 $130M -$218M -62.7% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $119M -$325M -73.2% Mar 31, 2023 10-Q 2023-04-27
Q4 2022 $131M -$453M -77.6% Dec 31, 2022 10-K 2024-02-29
Q3 2022 $184M -$494M -72.9% Sep 30, 2022 10-Q 2022-10-27
Q2 2022 $347M -$422M -54.9% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $444M -$398M -47.3% Mar 31, 2022 10-Q 2022-05-03
Q4 2021 $584M -$311M -34.8% Dec 31, 2021 10-K 2023-02-21
Q3 2021 $678M -$28.9M -4.09% Sep 30, 2021 10-Q 2021-10-28
Q2 2021 $770M +$429M +126% Jun 30, 2021 10-Q 2021-07-29
Q1 2021 $842M +$369M +78.1% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 $895M +$496M +125% Dec 31, 2020 10-K 2022-02-22
Q3 2020 $707M +$522M +282% Sep 30, 2020 10-Q 2020-10-29
Q2 2020 $340M +$113M +49.7% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $473M +$267M +129% Mar 31, 2020 10-Q 2020-04-30
Q4 2019 $399M +$340M +586% Dec 31, 2019 10-K 2021-02-25
Q3 2019 $185M +$143M +336% Sep 30, 2019 10-Q 2019-10-30
Q2 2019 $227M +$155M +215% Jun 30, 2019 10-Q 2019-08-06
Q1 2019 $206M +$125M +156% Mar 31, 2019 10-Q 2019-05-02
Q4 2018 $58.1M -$21.4M -26.9% Dec 31, 2018 10-K 2020-03-02
Q3 2018 $42.5M +$15M +54.7% Sep 30, 2018 10-Q 2018-11-05
Q2 2018 $72.3M +$24.3M +50.5% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 $80.6M -$67.9M -45.7% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 $79.5M -$93.9M -54.2% Dec 31, 2017 10-K 2019-03-01
Q3 2017 $27.5M -$171M -86.1% Sep 30, 2017 10-Q 2017-11-02
Q2 2017 $48.1M -$189M -79.7% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 $148M -$110M -42.6% Mar 31, 2017 10-Q 2017-05-08
Q4 2016 $173M -$108M -38.3% Dec 31, 2016 10-K 2018-03-06
Q3 2016 $198M -$32.8M -14.2% Sep 30, 2016 10-Q 2016-11-03
Q2 2016 $237M +$11.2M +4.97% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 $259M +$14.9M +6.12% Mar 31, 2016 10-Q 2016-05-05
Q4 2015 $281M +$15.4M +5.8% Dec 31, 2015 10-K 2017-03-16
Q3 2015 $231M +$74.3M +47.5% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 $226M +$20.3M +9.88% Jun 30, 2015 10-Q 2015-07-31
Q1 2015 $244M +$113M +86.4% Mar 31, 2015 10-Q 2015-05-05
Q4 2014 $265M +$138M +109% Dec 31, 2014 10-K 2016-02-29
Q3 2014 $157M +$23.3M +17.5% Sep 30, 2014 10-Q 2014-11-06
Q2 2014 $206M +$194M +1676% Jun 30, 2014 10-Q 2014-08-07
Q1 2014 $131M Mar 31, 2014 10-Q 2014-05-06
Q4 2013 $127M Dec 31, 2013 10-K 2015-03-02
Q3 2013 $133M Sep 30, 2013 10-Q 2013-11-14
Q2 2013 $11.6M Jun 30, 2013 10-Q 2013-08-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.